Search - tctmd.com

Displaying 681 - 700 of 1660

Sort: Relevancy | Date

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Caitlin E. Cox

March 10, 2017

Presentation SIF 2017

Complex Bifurcation Case

Presenter: Jasvindar Singh

March 10, 2017

News Daily News

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Todd Neale

March 06, 2017

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

L.A. McKeown

March 02, 2017

News Daily News

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

L.A. McKeown

February 27, 2017

News Conference News CRT 2017

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Michael O'Riordan

February 23, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2017

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

Michael O'Riordan

February 20, 2017

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

Presentation

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

February 17, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

Presentation JIM 2017

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

Presenter: Gregg W. Stone

February 10, 2017

Presentation JIM 2017

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Presenter: Sasko Kedev

February 10, 2017

Advertisement

REVA to Expand FANTOM II Trial to More Complex Cases

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

Complex Bifurcation Case

FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

Same-Day Discharge After Transradial PCI Safe, Feasible, With Significant Cost Savings

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Suspended Lead Curtain, Robotic PCI, Offer Significant Head Protection from Radiation During PCI

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

Bioresorbable Scaffolds: A Real Clinical Need? Yes!

“Clinical Outcome and My Experience of MeRes 100 BioResorbable Scaffold”

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content